Aptar Pharma collaborates with TFF Pharmaceuticals on dry powder vaccines
TFF Pharmaceutical’s Thin Film Freezing technology platform has broad applicability to convert drugs (small and large molecules) and vaccines into a dry powder formulation for local administration